Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
Background: Targeted therapy drugs, including imatinib, are used for inhibiting the marker oncoprotein of chronic myeloid leukemia — BCR-ABL tyrosine kinase. However, in some patients the drug resistance can emerge too rapidly and a previous treatment with chemotherapy drugs can lead to formation of...
Saved in:
Date: | 2014 |
---|---|
Main Authors: | Zhaleiko, I.O., Perekhrestenko, T.P., Bilko, D.I., Dyagil, I.S., Bilko, N.M. |
Format: | Article |
Language: | English |
Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
Series: | Experimental Oncology |
Subjects: | |
Online Access: | http://dspace.nbuv.gov.ua/handle/123456789/145345 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Cite this: | Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors / I.O. Zhaleiko, T.P. Perekhrestenko, D.I. Bilko, I.S. Dyagil, N.M. Bilko // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 112-116. — Бібліогр.: 19 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
by: I. O. Zhaleiko, et al.
Published: (2014) -
Circulating hematopoietic progenitor cells in patients affected by chornobyl accident
by: Bilko, N.M., et al.
Published: (2016) -
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
by: Sviezhentseva, I.O., et al.
Published: (2015) -
Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma
by: Petrushev, B., et al.
Published: (2012) -
Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer
by: Yakovlev, P., et al.
Published: (2018)